EPO and brain injury: Apart from enhancing the endogenous production level of EPO, the administration of exogenous rhEPO has been demonstrated to reduce ischemic brain injury and improve functional recovery both at the acute and late stages of cerebral ischemia in the pre-clinical and clinical studies.